Answers are grounded in this paper and cite their sources.
We document our experience with therapeutic drug monitoring (TDM) of antiretroviral agents (1807 determinations) carried out as day-by-day clinical practice for the optimization of drug dosing in HIV-infected patients. A significant proportion of patients had lopinavir, atazanavir and nevirapine trough concentrations exceeding the upper therapeutic threshold. Further studies are needed to identify good candidates/drugs for TDM, eventually allowing the selection of patients who may benefit from TDM-driven adjustments in antiretrovirals dosage.
No takes yet. Share an insight, caveat, or question.
Cattaneo et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: